Cargando…
Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium
The national vaccination campaign against SARS-CoV-2 started in January 2021 in Belgium. In the present study, we aimed to use national hospitalisation surveillance data to investigate the recent evolution of vaccine impact on the risk of COVID-19 hospitalisation. We analysed aggregated data from 27...
Autores principales: | Erazo, Diana, Vincenti-Gonzalez, Maria F., van Loenhout, Joris A. F., Hubin, Pierre, Vandromme, Mathil, Maes, Piet, Taquet, Maxime, Van Weyenbergh, Johan, Catteau, Lucy, Dellicour, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228783/ https://www.ncbi.nlm.nih.gov/pubmed/35746786 http://dx.doi.org/10.3390/v14061315 |
Ejemplares similares
-
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022
por: Braeye, Toon, et al.
Publicado: (2023) -
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium
por: Vermeiren, Elias, et al.
Publicado: (2023) -
Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021–2022
por: Van Goethem, Nina, et al.
Publicado: (2022) -
Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium
por: Stouten, Veerle, et al.
Publicado: (2022) -
Severity of infection with the SARS-CoV-2 B.1.1.7 lineage among hospitalized COVID-19 patients in Belgium
por: Van Goethem, Nina, et al.
Publicado: (2022)